RAC's strategy is unusual in biotech because they're not trying to establish themselves in crowded markets... like so many others.
RAC's strategy is unusual in biotech because they're not trying...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.180(11.5%) |
Mkt cap ! $296.8M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.80 | $1.58 | $772.4K | 450.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2354 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.76 | 525 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.75 |
Change
0.180 ( 11.2 %) |
||||
| Open | High | Low | Volume | ||
| $1.60 | $1.80 | $1.58 | 22024 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| RAC (ASX) Chart |